Am. J. Respir. Crit. Care Med., Volume 161, Number 6, June 2000, 1999-2004

Angiotensin II Is Mitogenic for Human Lung Fibroblasts via Activation of the Type 1 Receptor

RICHARD P. MARSHALL, ROBIN J. MCANULTY, and GEOFFREY J. LAURENT

Centre for Cardiopulmonary Biochemistry and Respiratory Medicine, Royal Free and University College London Medical School, Rayne Institute, London, United Kingdom

The expression of renin-angiotensin system components and the elevation of angiotensin-converting enzyme (ACE) in a number of fibrotic lung diseases suggests angiotensin II (AII) could play a role in the pathogenesis of pulmonary fibrosis. However, the effect of AII on lung fibroblasts has not previously been assessed and the mechanisms by which AII induces cell proliferation in mesenchymal cells are not fully understood. We have examined the ability of AII to stimulate fetal and adult human lung fibroblast proliferation in vitro. In particular, we have assessed the receptor subtypes involved and the possible autocrine role of transforming growth factor  (TGF-) and platelet-derived growth factor (PDGF), two recognized fibroblast mitogens. Angiotensin type 1 (AT1), but not type 2, receptors were identified on fetal and adult human lung fibroblasts by immunocytochemistry. AII (1 µM) increased DNA synthesis (determined by [³H]thymidine incorporation) in fetal and adult cells by 211 ± 18% and 150 ± 14%, respectively (p < 0.01), and was inhibited by a specific AT1 receptor antagonist, Losartan (74 ± 14%). A proliferative response to AII was confirmed by direct cell counts. Subsequently, fibroblasts were incubated with neutralizing antibodies to TGF- and PDGF. Anti-TGF- antibodies inhibited AII-induced DNA synthesis by 73 ± 13%. However, no effect was seen with anti-PDGF antibodies. In conclusion, we have shown that angiotensin II induces human lung fibroblast proliferation in vitro via activation of the AT1 receptor and involves the autocrine action of TGF-.

This article has been cited by other articles:

				A. Abdul-Hafez, R. Shu, and B. D. Uhal JunD and HIF-1{alpha} mediate transcriptional activation of angiotensinogen by TGF-{beta}1 in human lung fibroblasts FASEB J, June 1, 2009; 23(6): 1655 - 1662. [Abstract] [Full Text] [PDF]

				B. D. Uhal The role of apoptosis in pulmonary fibrosis Eur. Respir. Rev., December 1, 2008; 17(109): 138 - 144. [Abstract] [Full Text] [PDF]

				G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315. [Abstract] [Full Text] [PDF]

				D. A. Schwartz Genetic Analysis of Sporadic and Familial Interstitial Pneumonia Proceedings of the ATS, April 15, 2008; 5(3): 343 - 347. [Abstract] [Full Text] [PDF]

				M. Konigshoff, A. Wilhelm, A. Jahn, D. Sedding, O. V. Amarie, B. Eul, W. Seeger, L. Fink, A. Gunther, O. Eickelberg, et al. The Angiotensin II Receptor 2 Is Expressed and Mediates Angiotensin II Signaling in Lung Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 640 - 650. [Abstract] [Full Text] [PDF]

				M. Watanabe, W. Matsuyama, Y. Shirahama, H. Mitsuyama, K.-i. Oonakahara, S. Noma, I. Higashimoto, M. Osame, and K. Arimura Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation J. Immunol., May 1, 2007; 178(9): 5888 - 5898. [Abstract] [Full Text] [PDF]

				X. Li, M. Molina-Molina, A. Abdul-Hafez, J. Ramirez, A. Serrano-Mollar, A. Xaubet, and B. D. Uhal Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L887 - L895. [Abstract] [Full Text] [PDF]

				M Miyawaki, T Okutani, R Higuchi, and N Yoshikawa Plasma angiotensin II concentrations in the early neonatal period Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2006; 91(5): F359 - F362. [Abstract] [Full Text] [PDF]

				M Molina-Molina, A Serrano-Mollar, O Bulbena, L Fernandez-Zabalegui, D Closa, A Marin-Arguedas, A Torrego, J Mullol, C Picado, and A Xaubet Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis Thorax, July 1, 2006; 61(7): 604 - 610. [Abstract] [Full Text] [PDF]

				G.B. J. Mancini, M. Etminan, B. Zhang, L. E. Levesque, J. M. FitzGerald, and J. M. Brophy Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary Disease J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2554 - 2560. [Abstract] [Full Text] [PDF]

				Z. Huang, L. Taylor, B. Liu, J. Yu, and P. Polgar Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1291 - L1299. [Abstract] [Full Text] [PDF]

				N. Walter, H. R. Collard, and T. E. King Jr. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proceedings of the ATS, January 1, 2006; 3(4): 330 - 338. [Abstract] [Full Text] [PDF]

				K. A. Keogh, J. Standing, G. C. Kane, A. Terzic, and A. H. Limper Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice Eur. Respir. J., April 1, 2005; 25(4): 708 - 714. [Abstract] [Full Text] [PDF]

				H. F. Nadrous, J. H. Ryu, W. W. Douglas, P. A. Decker, and E. J. Olson Impact of Angiotensin-Converting Enzyme Inhibitors and Statins on Survival in Idiopathic Pulmonary Fibrosis Chest, August 1, 2004; 126(2): 438 - 446. [Abstract] [Full Text] [PDF]

				R. M. Day, G. Thiel, J. Lum, R. D. Chevere, Y. Yang, J. Stevens, L. Sibert, and B. L. Fanburg Hepatocyte Growth Factor Regulates Angiotensin Converting Enzyme Expression J. Biol. Chem., March 5, 2004; 279(10): 8792 - 8801. [Abstract] [Full Text] [PDF]

				U. Bartram and C. P. Speer The Role of Transforming Growth Factor {beta} in Lung Development and Disease Chest, February 1, 2004; 125(2): 754 - 765. [Abstract] [Full Text] [PDF]

				M Otsuka, H Takahashi, M Shiratori, H Chiba, and S Abe Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax, January 1, 2004; 59(1): 31 - 38. [Abstract] [Full Text] [PDF]

				R. P. Marshall, P. Gohlke, R. C. Chambers, D. C. Howell, S. E. Bottoms, T. Unger, R. J. McAnulty, and G. J. Laurent Angiotensin II and the fibroproliferative response to acute lung injury Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L156 - L164. [Abstract] [Full Text] [PDF]

				X. Li, H. Rayford, and B. D. Uhal Essential Roles for Angiotensin Receptor AT1a in Bleomycin-Induced Apoptosis and Lung Fibrosis in Mice Am. J. Pathol., December 1, 2003; 163(6): 2523 - 2530. [Abstract] [Full Text]

				R. Bataller, E. Gabele, R. Schoonhoven, T. Morris, M. Lehnert, L. Yang, D. A. Brenner, and R. A. Rippe Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G642 - G651. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				R. M. Day, Y. Yang, Y. J. Suzuki, J. Stevens, R. Pathi, A. Perlmutter, B. L. Fanburg, and J. J. Lanzillo Bleomycin Upregulates Gene Expression of Angiotensin-Converting Enzyme via Mitogen-Activated Protein Kinase and Early Growth Response 1 Transcription Factor Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 613 - 619. [Abstract] [Full Text] [PDF]

				T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF]